- Home
- SLNO vs SLG Comparison
SLNO vs SLG Comparison
Compare SLNO & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- SLG
- Stock Information
- Founded
- SLNO 1999
- SLG 1980
- Country
- SLNO United States
- SLG United States
- Employees
- SLNO N/A
- SLG N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SLG Real Estate Investment Trusts
- Sector
- SLNO Health Care
- SLG Real Estate
- Exchange
- SLNO Nasdaq
- SLG Nasdaq
- Market Cap
- SLNO 3.7B
- SLG 3.4B
- IPO Year
- SLNO 2014
- SLG 1997
- Fundamental
- Price
- SLNO $48.65
- SLG $44.67
- Analyst Decision
- SLNO Strong Buy
- SLG Buy
- Analyst Count
- SLNO 10
- SLG 15
- Target Price
- SLNO $110.90
- SLG $63.00
- AVG Volume (30 Days)
- SLNO 2.3M
- SLG 1.2M
- Earning Date
- SLNO 11-04-2025
- SLG 10-15-2025
- Dividend Yield
- SLNO N/A
- SLG 6.94%
- EPS Growth
- SLNO N/A
- SLG N/A
- EPS
- SLNO N/A
- SLG N/A
- Revenue
- SLNO $98,675,000.00
- SLG $661,814,000.00
- Revenue This Year
- SLNO N/A
- SLG N/A
- Revenue Next Year
- SLNO $181.30
- SLG $9.79
- P/E Ratio
- SLNO N/A
- SLG N/A
- Revenue Growth
- SLNO N/A
- SLG N/A
- 52 Week Low
- SLNO $41.50
- SLG $43.75
- 52 Week High
- SLNO $90.32
- SLG $80.90
- Technical
- Relative Strength Index (RSI)
- SLNO 38.14
- SLG 24.54
- Support Level
- SLNO $46.82
- SLG $49.20
- Resistance Level
- SLNO $50.04
- SLG $51.25
- Average True Range (ATR)
- SLNO 3.65
- SLG 1.74
- MACD
- SLNO -0.83
- SLG -0.44
- Stochastic Oscillator
- SLNO 22.23
- SLG 10.42
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.